FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wyndham Wilson

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

B-Lymphocytes

Co-author Network

Publications

TOP 3
Kieron Dunleavy; Cliona Grant; Julie Hessler; Elaine S Jaffe; Lauren S Maeda; Stefania Pittaluga; Louis M Staudt; Seth M Steinberg; Gaurav Varma; Ranjana Advani; Clara C Chen; George Wright; Wyndham H Wilson
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
Kieron Dunleavy; Cliona Grant; Wyndham H Wilson
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.
Mark Roschewski; Kieron Dunleavy; Wyndham H Wilson
Diffuse large B cell lymphoma: molecular targeted therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wyndham Wilson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kieron Dunleavy; Cliona Grant; Julie Hessler; Elaine S Jaffe; Lauren S Maeda; Stefania Pittaluga; Louis M Staudt; Seth M Steinberg; Gaurav Varma; Ranjana Advani; Clara C Chen; George Wright; Wyndham H Wilson
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
The New England journal of medicine 2013;368(15):1408-16.
2013: Kieron Dunleavy; Cliona Grant; Wyndham H Wilson
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma.
Therapeutic advances in hematology 2013;4(1):43-57.
2012: Mark Roschewski; Kieron Dunleavy; Wyndham H Wilson
Diffuse large B cell lymphoma: molecular targeted therapy.
International journal of hematology 2012;96(5):552-61.
2012: Matthew S Davids; Jing Deng; Brian J Lannutti; Lili Wang; Adrian Wiestner; Wyndham H Wilson; Catherine J Wu; Jennifer R Brown; Anthony Letai
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
Blood 2012;120(17):3501-9.
2012: Mark Roschewski; Wyndham H Wilson
Lymphomatoid granulomatosis.
Cancer journal (Sudbury, Mass.) 2012;18(5):469-74.
2012: Kieron Dunleavy; Franziska C Eberle; Cliona Grant; Elaine S Jaffe; Stefania Pittaluga; Wyndham H Wilson
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
Current hematologic malignancy reports 2012;7(3):241-7.
2012: Kieron Dunleavy; Mark Roschewski; Wyndham H Wilson
Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes.
Current hematologic malignancy reports 2012;7(3):208-15.
2012: Robert J Kreitman; Robert Lechleider; Steven Coutre; David J Fitzgerald; Tadeusz Robak; Maryalice Stetler-Stevenson; Martin S Tallman; Wyndham H Wilson; Ira Pastan
Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(15):1822-8.
2012: Sivasubramanian Baskar; Ira Pastan; Adrian Wiestner; Wyndham H Wilson; Christoph Rader
Targeting malignant B cells with an immunotoxin against ROR1.
mAbs 2012;4(3):349-61.
2012: Franziska C Eberle; Nancy Lee Harris; Stefania Pittaluga; Mark Raffeld; Joo Y Song; Wyndham H Wilson; Liqiang Xi; Elaine S Jaffe
Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
The American journal of surgical pathology 2012;36(5):716-25.
2012: Wyndham H Wilson; Andrew D Zelenetz; George Canellos; Amy Chadburn; Bruce D Cheson; Myron Czuczman; Kieron Dunleavy; Eric D Hsi; David Hurd; Jeffrey Johnson; Dan Jones; Sin-Ho Jung; Raymond Lai; S Eric Martin; Pierluigi Porcu; Jonathan Said
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
Haematologica 2012;97(5):758-65.
2012: Kieron Dunleavy; Wyndham H Wilson
How I treat HIV-associated lymphoma.
Blood 2012;119(14):3245-55.
2012: James N Kochenderfer; Carolyn Laurencot; Irina Maric; Richard A Morgan; Debbie-Ann N Nathan; Giao Q Phan; Robert Carpenter; Laura Devillier; Mark E Dudley; Steven A Feldman; Marybeth S Hughes; Udai S Kammula; Richard M Sherry; David E Spaner; Maryalice Stetler-Stevenson; Wyndham H Wilson; James C Yang; STEVEN ROSENBERG
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
Blood 2012;119(12):2709-20.
2012: Rachel B Salit; Seth M Steinberg; Wyndham H Wilson; Kelly Bryant; Robert M Dean; Kieron Dunleavy; Daniel H Fowler; Terry J Fry; Ronald E Gress; Frances Hakim; Thomas E Hughes; Jeanne Odom; Steven Z Pavletic; Michael Bishop
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(8):830-6.
2012: Mark Roschewski; Wyndham H Wilson
EBV-associated lymphomas in adults.
Best practice & research. Clinical haematology 2012;25(1):75-89.
2012: Heba A Degheidy; Mohammed Z H Farooqui; Fatima Abbasi; Diane C Arthur; M A Stetler-Stevenson; David J Venzon; Adrian Wiestner; Wyndham H Wilson; Gerald E Marti
Combined normal donor and CLL: Single tube ZAP-70 analysis.
Cytometry. Part B, Clinical cytometry 2012;82(2):67-77.
2011: Franziska C Eberle; Randy D Gascoyne; Stephen M Hewitt; Kieron Dunleavy; David Liewehr; Susana Ben Neriah; Stefania Pittaluga; Mark Raffeld; Jaime Rodriguez-Canales; Itziar Salaverria; Reiner Siebert; Christian Steidl; Thomas A Summers; Wyndham H Wilson; Liqiang Xi; Kris Ylaya; Elaine S Jaffe
Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(12):1586-97.
2011: Gerald E Marti; Seth M Steinberg; Maryalice Stetler-Stevenson; Tanyifor Tohnya; Therese White; Kieron Dunleavy; William D Figg; Nicole Drbohlav Grant; Elaine S Jaffe; John E Janik; Wyndham H Wilson
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.
Leukemia & lymphoma 2011;52(12):2284-92.
2011: Brad Moriyama; Scott R Penzak; Wyndham H Wilson; Oluwaseun Falade-Nwulia; Stacey A Henning; Xuan Huang; Caroline JJingo; Janice Leung; THOMAS WALSH
Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction.
Mycoses 2011;54(6):e877-9.
2011: Heba A Degheidy; Mohammed Z H Farooqui; Fatima Abbasi; Diane C Arthur; M A Stetler-Stevenson; David J Venzon; Adrian Wiestner; Wyndham H Wilson; Gerald E Marti
Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation.
Cytometry. Part B, Clinical cytometry 2011;80(5):309-17.
2011: Heba A Degheidy; Mohammed Z H Farooqui; Fatima Abbasi; Diane C Arthur; M A Stetler-Stevenson; David J Venzon; Adrian Wiestner; Wyndham H Wilson; Gerald E Marti
Methodological comparison of two anti-ZAP-70 antibodies.
Cytometry. Part B, Clinical cytometry 2011;80(5):300-8.
2011: Marc A Weniger; Therese White; Wyndham H Wilson; Yihong Ye; Kieron Dunleavy; Delong Liu; Peter J Munson; Patricia Pérez-Galán; Nalini Raghavachari; Edgar G Rizzatti; Megan M Tweito; Qiuyan Wang; Adrian Wiestner
Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(15):5101-12.
2011: Robert J Kreitman; Evgeny Arons; Maryalice Stetler-Stevenson; David J P Fitzgerald; Wyndham H Wilson; Ira Pastan
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia.
Leukemia & lymphoma 2011;52 Suppl 2():82-6.
2011: Joo Y Song; Franziska C Eberle; Liqiang Xi; Mark Raffeld; Osama Rahma; Wyndham H Wilson; Kieron Dunleavy; Stefania Pittaluga; Elaine S Jaffe
Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.
The American journal of surgical pathology 2011;35(5):767-72.
2011: Franziska C Eberle; Jaime Rodriguez-Canales; Lai Wei; Jeffrey C Hanson; J Keith Killian; Hong-Wei Sun; Lisa G Adams; Stephen M Hewitt; Wyndham H Wilson; Stefania Pittaluga; Paul S Meltzer; Louis M Staudt; Michael R Emmert-Buck; Elaine S Jaffe
Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.
Haematologica 2011;96(4):558-66.
2011: Adnan Mansoor; Stefania Pittaluga; Paul L Beck; Wyndham H Wilson; Judith A Ferry; Elaine S Jaffe
NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series.
Blood 2011;117(5):1447-52.
2011: Ram Savan; Adelle P McFarland; Della A Reynolds; Lionel Feigenbaum; Karthika Ramakrishnan; Megan Karwan; Hidekazu Shirota; Dennis M Klinman; Kieron Dunleavy; Stefania Pittaluga; Stephen K Anderson; Raymond P Donnelly; Wyndham H Wilson; Howard A Young
A novel role for IL-22R1 as a driver of inflammation.
Blood 2011;117(2):575-84.
2011: Patricia Pérez-Galán; Helena Mora-Jensen; Marc A Weniger; Arthur L Shaffer; Edgar G Rizzatti; Colby M Chapman; Clifton C Mo; Lawrence S Stennett; Christoph Rader; Poching Liu; Nalini Raghavachari; Maryalice Stetler-Stevenson; Constance Yuan; Stefania Pittaluga; Irina Maric; Kieron M Dunleavy; Wyndham H Wilson; Louis M Staudt; Adrian Wiestner
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.
Blood 2011;117(2):542-52.
2011: Yair Herishanu; Patricia Pérez-Galán; Delong Liu; Angélique Biancotto; Stefania Pittaluga; Berengere Vire; Federica Gibellini; Ndegwa Njuguna; Elinor Lee; Lawrence Stennett; Nalini Raghavachari; Poching Liu; J Philip McCoy; Mark Raffeld; Maryalice Stetler-Stevenson; Constance Yuan; Richard Sherry; Diane C Arthur; Irina Maric; Therese White; Gerald E Marti; Peter J Munson; Wyndham H Wilson; Adrian Wiestner
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Blood 2011;117(2):563-74.
2011: Michael E Williams; Joseph Michael Connors; Martin Dreyling; Randy D Gascoyne; Brad S Kahl; John P Leonard; Oliver W Press; Wyndham H Wilson
Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
Leukemia & lymphoma 2011;52(1):24-33.
2010: Kieron Dunleavy; Richard L Piekarz; Jasmine Zain; John E Janik; Wyndham H Wilson; Owen A O'Connor; Susan E Bates
New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(23):5608-17.
2010: Wyndham H Wilson; Owen A O'Connor; Myron S Czuczman; Ann S LaCasce; John Gerecitano; John P Leonard; Anil Tulpule; Kieron Dunleavy; Hao Xiong; Yi-Lin Chiu; Yue Cui; Todd Busman; Steven W Elmore; Saul H Rosenberg; Andrew Krivoshik; Sari H Enschede; Rod A Humerickhouse
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.
The lancet oncology 2010;11(12):1149-59.
2010: James N Kochenderfer; Wyndham H Wilson; John E Janik; Mark E Dudley; Maryalice Stetler-Stevenson; Steven A Feldman; Irina Maric; Mark Raffeld; Debbie-Ann N Nathan; Brock J Lanier; Richard A Morgan; STEVEN ROSENBERG
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
Blood 2010;116(20):4099-102.
2010: Liqiang Xi; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.
The American journal of surgical pathology 2010;34(10):1425-35.
2010: Kieron Dunleavy; Wyndham H Wilson
Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma.
Leukemia & lymphoma 2010;51(9):1583-4.
2010: Kieron Dunleavy; George Mikhaeel; Laurie H Sehn; Rodney J Hicks; Wyndham H Wilson
The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma.
Leukemia & lymphoma 2010;51 Suppl 1():28-33.
2010: Wyndham H Wilson; Francisco J Hernandez-Ilizaliturri; Kieron Dunleavy; Richard F Little; Owen A O'Connor
Novel disease targets and management approaches for diffuse large B-cell lymphoma.
Leukemia & lymphoma 2010;51 Suppl 1():1-10.
2010: Kieron Dunleavy; Wyndham H Wilson
Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(16):e260; author reply e261-2.
2010: Kieron Dunleavy; Richard F Little; Stefania Pittaluga; Nicole Grant; ALAN WAYNE; Jorge Carrasquillo; Seth M Steinberg; Robert Yarchoan; Elaine S Jaffe; Wyndham H Wilson
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Blood 2010;115(15):3017-24.
2010: Kieron Dunleavy; Kevin Tay; Wyndham H Wilson
Rituximab-associated neutropenia.
Seminars in hematology 2010;47(2):180-6.
2010: Kevin Tay; Kieron Dunleavy; Wyndham H Wilson
Novel agents for B-cell non-Hodgkin lymphoma: science and the promise.
Blood reviews 2010;24(2):69-82.
2010: Michael E Williams; Martin H Dreyling; Brad S Kahl; John P Leonard; Owen A O'Connor; Oliver W Press; Wyndham H Wilson
Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop.
Leukemia & lymphoma 2010;51(3):390-8.
2010: Ola Landgren; James J Goedert; Charles S Rabkin; Wyndham H Wilson; Kieron Dunleavy; Robert A Kyle; Jerry A Katzmann; S Vincent Rajkumar; Eric A Engels
Circulating serum free light chains as predictive markers of AIDS-related lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):773-9.
2010: Mark Roschewski; Wyndham H Wilson
Biology and management of rare primary extranodal T-cell lymphomas.
Oncology (Williston Park, N.Y.) 2010;24(1):94-100.
2009: Kevin Tay; Kieron Dunleavy; Wyndham H Wilson
Targeting HLA-DR.
Leukemia & lymphoma 2009;50(12):1911-3.
2009: Ola Landgren; Kieron Dunleavy; Wyndham H Wilson
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
Journal of the National Cancer Institute 2009;101(18):1287-8; author reply 1289-90.
2009: Georg Aue; Ndegwa Njuguna; Xin Tian; Susan Soto; Thomas Hughes; Berengere Vire; Keyvan Keyvanfar; Federica Gibellini; Janet Valdez; Carol Boss; Leigh Samsel; J Philip McCoy; Wyndham H Wilson; Stefania Pittaluga; Adrian Wiestner
Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia.
Haematologica 2009;94(9):1266-73.
2009: Sigurdur Y Kristinsson; Paul Dickman; Wyndham H Wilson; Neil Caporaso; Magnus Björkholm; Ola Landgren
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden.
Haematologica 2009;94(9):1259-65.
2009: James N Kochenderfer; Steven A Feldman; Yangbing Zhao; Hui Xu; Mary A Black; Richard A Morgan; Wyndham H Wilson; STEVEN ROSENBERG
Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(7):689-702.
2009: Marc C Chamberlain; Michael Glantz; Morris D Groves; Wyndham H Wilson
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
Seminars in oncology 2009;36(4 Suppl 2):S35-45.
2009: Robert J Kreitman; Maryalice Stetler-Stevenson; Inger Margulies; Pierre Noel; David J P Fitzgerald; Wyndham H Wilson; Ira Pastan
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2983-90.
2009: Kieron Dunleavy; Stefania Pittaluga; Myron S Czuczman; Sandeep S Dave; George Wright; Nicole Grant; Margaret Shovlin; Elaine S Jaffe; John Janik; Louis M Staudt; Wyndham H Wilson
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.
Blood 2009;113(24):6069-76.
2008: Ken H Young; Karen Leroy; Michael B Møller; Gisele W B Colleoni; Margarita Sánchez-Beato; Fábio R Kerbauy; Corinne Haioun; Jens Eickhoff; Allen H Young; Philippe Gaulard; Miguel A Piris; Terry D Oberley; William M Rehrauer; Brad S Kahl; James S Malter; Elias Campo; Jan Delabie; Randy D Gascoyne; Andreas Rosenwald; Lisa M Rimsza; James Huang; Rita M Braziel; Elaine S Jaffe; Wyndham H Wilson; Louis M Staudt; Julie M Vose; Wing C Chan; Dennis D Weisenburger; Timothy C Greiner
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
Blood 2008;112(8):3088-98.
2008: Rabie M Shanti; Carlos A Torres-Cabala; Elaine S Jaffe; Wyndham H Wilson; Jaime Brahim
Lymphomatoid granulomatosis with involvement of the hard palate: a case report.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2008;66(10):2161-3.
2008: Deirdre O'Mahony; Richard L Peikarz; W Patricia Bandettini; Andrew Arai; Wyndham H Wilson; Susan E Bates
Cardiac involvement with lymphoma: a review of the literature.
Clinical lymphoma & myeloma 2008;8(4):249-52.
2008: Wyndham H Wilson; Kieron Dunleavy; Stefania Pittaluga; Upendra Hegde; Nicole Grant; Seth M Steinberg; Mark Raffeld; Martin Gutierrez; Bruce A Chabner; Louis M Staudt; Elaine S Jaffe; John Janik
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2717-24.
2008: Sam T Hwang; John Janik; Elaine S Jaffe; Wyndham H Wilson
Mycosis fungoides and Sézary syndrome.
Lancet 2008;371(9616):945-57.
2008: Sivasubramanian Baskar; Ka Yin Kwong; Thomas Hofer; Jessica M Levy; Michael G Kennedy; Elinor Lee; Louis M Staudt; Wyndham H Wilson; Adrian Wiestner; Christoph Rader
Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(2):396-404.
2007: Kieron Dunleavy; Wyndham H Wilson; Elaine S Jaffe
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.
Current opinion in hematology 2007;14(4):348-53.
2007: Kieron Dunleavy; Louis M Staudt; Wyndham H Wilson
The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma.
Leukemia & lymphoma 2007;48(6):1061-3.
2007: Adrian Wiestner; Mahsa Tehrani; Michael Chiorazzi; George Wright; Federica Gibellini; Kazutaka Nakayama; Hui Liu; Andreas Rosenwald; H Konrad Muller-Hermelink; German Ott; Wing C Chan; Timothy C Greiner; Dennis D Weisenburger; Julie M Vose; James O Armitage; Randy D Gascoyne; Joseph Michael Connors; Elias Campo; Emili Montserrat; Francesc Bosch; Erlend Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Richard I Fisher; Thomas M Grogan; Thomas P Miller; Wyndham H Wilson; Elaine S Jaffe; Louis M Staudt
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Blood 2007;109(11):4599-606.
2007: Kieron Dunleavy; Wyndham H Wilson
Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy.
Leukemia & lymphoma 2007;48(3):449-51.
2007: Deirdre O'Mahony; John C Morris; Cate Quinn; Wendy Gao; Wyndham H Wilson; Barry L Gause; Stefania Pittaluga; Sattva S Neelapu; Margaret Brown; Thomas A Fleisher; James L Gulley; Jeffrey Schlom; Robert B Nussenblatt; Paul Albert; Thomas A Davis; Israel Lowy; Mike Petrus; Thomas Waldmann; John Janik
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):958-64.
2007: Kieron Dunleavy; R Eric Davis; Ola Landgren; Louis M Staudt; Wyndham H Wilson
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
Blood 2007;109(2):843-4; discussion 844-5.
2007: Wyndham H Wilson
International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia.
Cytometry. Part B, Clinical cytometry 2007;72 Suppl 1():S2.
2007: T Ise; Satoshi Nagata; Robert J Kreitman; Wyndham H Wilson; ALAN WAYNE; Maryalice Stetler-Stevenson; Michael Bishop; David A Scheinberg; Laura Rassenti; Thomas Kipps; R A Kyle; D F Jelinek; Ira Pastan
Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
Leukemia 2007;21(1):169-74.
2006: Wyndham H Wilson
Drug resistance in diffuse large B-cell lymphoma.
Seminars in hematology 2006;43(4):230-9.
2006: Kieron Dunleavy; Wyndham H Wilson
Primary intraocular lymphoma: current and future perspectives.
Leukemia & lymphoma 2006;47(9):1726-7.
2006: Wendy B Bernstein; Richard F Little; Wyndham H Wilson; Robert Yarchoan
Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy.
International journal of hematology 2006;84(1):3-11.
2006: Robert B Nussenblatt; Chi-Chao Chan; Wyndham H Wilson; Jacob Hochman; Michael M Gottesman
International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future.
Ocular immunology and inflammation 2006;14(3):139-44.
2006: Hyuncheol Kim; Karl G Csaky; Chi-Chao Chan; Peter M Bungay; Robert J Lutz; Robert L Dedrick; Peng Yuan; Jay Rosenberg; Antonio J Grillo-Lopez; Wyndham H Wilson; Michael R Robinson
The pharmacokinetics of rituximab following an intravitreal injection.
Experimental eye research 2006;82(5):760-6.
2006: Kieron Dunleavy; Wyndham H Wilson; Lawrence D Kaplan
The case for rituximab in AIDS-related lymphoma.
Blood 2006;107(7):3014-5.
2006: Deepak Sudheendra; Mara M Barth; Upendra Hegde; Wyndham H Wilson; Bradford J Wood
Radiofrequency ablation of lymphoma.
Blood 2006;107(4):1624-6.
2005: Kai Fu; Dennis D Weisenburger; Timothy C Greiner; Sandeep Dave; George Wright; Andreas Rosenwald; Michael Chiorazzi; Javeed Iqbal; Stefan Gesk; Reiner Siebert; Daphne De Jong; Elaine S Jaffe; Wyndham H Wilson; Jan Delabie; German Ott; Bhavana J Dave; Warren G Sanger; Lynette M Smith; Lisa M Rimsza; Rita M Braziel; Hans Konrad Müller-Hermelink; Elias Campo; Randy D Gascoyne; Louis M Staudt; Wing C Chan
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.
Blood 2005;106(13):4315-21.
2005: Athos Patsalides; Gokce Atac; Upendra Hedge; John Janik; Nicole Grant; Elaine S Jaffe; Andrew J Dwyer; Nicholas Patronas; Wyndham H Wilson
Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging.
Radiology 2005;237(1):265-73.
2005: Robert J Kreitman; David R Squires; Maryalice Stetler-Stevenson; Pierre Noel; David J P FitzGerald; Wyndham H Wilson; Ira Pastan
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6719-29.
2005: Sattva S Neelapu; Larry W Kwak; CAROL KOBRIN; Craig W Reynolds; John Janik; Kieron Dunleavy; Therese White; Linda Harvey; Robin Pennington; Maryalice Stetler-Stevenson; Elaine S Jaffe; Seth M Steinberg; Ronald E Gress; Frances T Hakim; Wyndham H Wilson
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
Nature medicine 2005;11(9):986-91.
2005: Robert M Dean; Daniel H Fowler; Wyndham H Wilson; Jeanne Odom; Seth M Steinberg; Catherine Chow; Claude Kasten-Sportes; Ronald E Gress; Michael Bishop
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(8):593-9.
2005: Kieron Dunleavy; Frances T Hakim; Hyun Kyung Kim; John Janik; Nicole Grant; Takayuki Nakayama; Therese White; George Wright; Larry W Kwak; Ronald E Gress; Giovanna Tosato; Wyndham H Wilson
B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis.
Blood 2005;106(3):795-802.
2005: Upendra Hegde; Armando C Filie; Richard F Little; John Janik; Nicole Grant; Seth M Steinberg; Kieron Dunleavy; Elaine S Jaffe; Andrea Abati; Maryalice Stetler-Stevenson; Wyndham H Wilson
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.
Blood 2005;105(2):496-502.
2004: Gregory D Leonard; Edwin Posadas; Paul C Herrmann; Victoria L Anderson; Elaine S Jaffe; Steven M Holland; Wyndham H Wilson
Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review.
Leukemia & lymphoma 2004;45(12):2521-5.
2004: W Tait Stevens; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Susan F Leitman; Charles D Bolan
Transfusion medicine illustrated. Hemophagocytosis and coagulopathy associated with cutaneous gamma-delta T-cell lymphoma.
Transfusion 2004;44(12):1679.
2004: John Janik; John C Morris; Stefania Pittaluga; Kristin McDonald; Mark Raffeld; Elaine S Jaffe; Nicole Grant; Martin Gutierrez; Thomas Waldmann; Wyndham H Wilson
Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.
Blood 2004;104(10):3355-7.
2004: Andreas Rosenwald; Eric Y Chuang; R Eric Davis; Adrian Wiestner; Ash A Alizadeh; Diane C Arthur; James B Mitchell; Gerald E Marti; Daniel H Fowler; Wyndham H Wilson; Louis M Staudt
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response.
Blood 2004;104(5):1428-34.
2004: Joanne Murdock; Elaine S Jaffe; Wyndham H Wilson; Damian T McManus; H Denis Alexander; T C M Morris
Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literature.
Leukemia & lymphoma 2004;45(6):1269-73.
2004: Matthew Lunning; Vincent E Zenger; Ricardo Dreyfuss; Maryalice Stetler-Stevenson; Margaret E Rick; Therese A White; Wyndham H Wilson; Gerald E Marti
Albumin enhanced morphometric image analysis in CLL.
Cytometry. Part B, Clinical cytometry 2004;57(1):7-14.
2003: Gregory D Leonard; Upendra Hegde; John A Butman; Elaine S Jaffe; Wyndham H Wilson
Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2993-5.
2003: Richard F Little; Stefania Pittaluga; Nicole Grant; Seth M Steinberg; Mark F Kavlick; Hiroaki Mitsuya; Genoveffa Franchini; Martin Gutierrez; Mark Raffeld; Elaine S Jaffe; Gene Shearer; Robert Yarchoan; Wyndham H Wilson
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
Blood 2003;101(12):4653-9.
2003: Adrian Wiestner; Andreas Rosenwald; Todd S Barry; George Wright; R Eric Davis; Sarah Henrickson; Hong Zhao; Rachel E Ibbotson; Jenny A Orchard; Zadie Davis; Maryalice Stetler-Stevenson; Mark Raffeld; Diane C Arthur; Gerald E Marti; Wyndham H Wilson; Terry J Hamblin; David Oscier; Louis M Staudt
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Blood 2003;101(12):4944-51.
2003: Michael Bishop; Jeannie Whit-Shan Hou; Wyndham H Wilson; Seth M Steinberg; Jeanne Odom; Kathleen Castro; Claude Kasten-Sportes; Juan Gea-Banacloche; Donna Marchigiani; Ronald E Gress; Daniel H Fowler
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):162-9.
2002: Louis M Staudt; Wyndham H Wilson
Focus on lymphomas.
Cancer cell 2002;2(5):363-6.
2002: Upendra Hegde; Wyndham H Wilson; Therese White; Bruce D Cheson
Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Blood 2002;100(6):2260-2.
2002: Wyndham H Wilson; Michael L Grossbard; Stefania Pittaluga; Diane Cole; Deborah Pearson; Nicole Drbohlav; Seth M Steinberg; Richard F Little; John Janik; Martin Gutierrez; Mark Raffeld; Louis Staudt; Bruce D Cheson; Dan Longo; Nancy Harris; Elaine S Jaffe; Bruce A Chabner; Robert Wittes; FRANK BALIS
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy.
Blood 2002;99(8):2685-93.
2002: Wyndham H Wilson; Martin Gutierrez; Paula O'Connor; Stanley Frankel; Elaine Jaffe; Bruce A Chabner; Michael L Grossbard
The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R.
Seminars in oncology 2002;29(1 Suppl 2):41-7.
2001: Andreas Rosenwald; A A Alizadeh; George F Widhopf; R Simon; R Eric Davis; X Yu; L Yang; Oxana Pickeral; Laura Rassenti; J Powell; D Botstein; J C Byrd; M R Grever; B D Cheson; Nicholas Chiorazzi; Wyndham H Wilson; Thomas Kipps; P O Brown; Louis M Staudt
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.
The Journal of experimental medicine 2001;194(11):1639-47.
2001: Richard L Piekarz; Robert W Robey; Victor A Sandor; Susan Bakke; Wyndham H Wilson; L Dahmoush; D M Kingma; Maria L Turner; Rosemary M Altemus; Susan E Bates
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report.
Blood 2001;98(9):2865-8.
2001: Michael Beaty; J Toro; Lynn Sorbara; Jere B Stern; Stefania Pittaluga; Mark Raffeld; Wyndham H Wilson; Elaine S Jaffe
Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features.
The American journal of surgical pathology 2001;25(9):1111-20.
2001: Robert J Kreitman; Wyndham H Wilson; K Bergeron; M Raggio; Maryalice Stetler-Stevenson; David J FitzGerald; Ira Pastan
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.
The New England journal of medicine 2001;345(4):241-7.
2001: Upendra Hegde; Wyndham H Wilson
Gene expression profiling of lymphomas.
Current oncology reports 2001;3(3):243-9.
2001: Muhammad Wasif Saif; Richard F Little; J Michael Hamilton; Carmen J Allegra; Wyndham H Wilson
Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):123-9.
2000: Wyndham H Wilson
Chemotherapy sensitization by rituximab: experimental and clinical evidence.
Seminars in oncology 2000;27(6 Suppl 12):30-6.
2000: M Gutierrez; Bruce A Chabner; Deborah Pearson; Seth M Steinberg; Elaine S Jaffe; Bruce D Cheson; Antonio Tito Fojo; Wyndham H Wilson
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21):3633-42.
2000: Richard F Little; Robert Yarchoan; Wyndham H Wilson
Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy.
Current opinion in oncology 2000;12(5):438-44.
2000: Dan Longo; PL Duffey; J G Gribben; Elaine S Jaffe; Brendan D Curti; Barry L Gause; John Janik; V M Braman; Dixie Esseltine; Wyndham H Wilson; D Kaufman; Robert Wittes; Lee M Nadler; W J Urba
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Cancer journal (Sudbury, Mass.) 2000;6(3):146-50.
2000: Robert J Kreitman; Wyndham H Wilson; Jeffrey D White; Maryalice Stetler-Stevenson; Elaine S Jaffe; S Giardina; Thomas Waldmann; Ira Pastan
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1622-36.
2000: Wyndham H Wilson; Lynn Sorbara; William D Figg; E K Mont; Edward A Sausville; Katherine E Warren; FRANK BALIS; Kenneth S. Bauer; Mark Raffeld; Adrian M Senderowicz; Anne Monks
Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):415-21.
2000: Philippe C Bishop; V Koneti Rao; Wyndham H Wilson
Burkitt's lymphoma: molecular pathogenesis and treatment.
Cancer investigation 2000;18(6):574-83.
1999: Robert J Kreitman; Wyndham H Wilson; D Robbins; Inger Margulies; Maryalice Stetler-Stevenson; Thomas Waldmann; Ira Pastan
Responses in refractory hairy cell leukemia to a recombinant immunotoxin.
Blood 1999;94(10):3340-8.
1999: Philippe C Bishop; Wyndham H Wilson; Deborah Pearson; John Janik; Elaine S Jaffe; PC Elwood
CNS involvement in primary mediastinal large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2479-85.
1998: Wyndham H Wilson; R Little; Deborah Pearson; Elaine S Jaffe; Seth M Steinberg; Bruce D Cheson; Rachel Humphrey; David R Kohler; PC Elwood
Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2345-51.
1998: Lauri Welles; MW Saville; JA Lietzau; James M Pluda; Kathleen M Wyvill; I Feuerstein; William D Figg; Richard M Lush; J Odom; Wyndham H Wilson; M T Fajardo; Rachel Humphrey; Ellen G Feigal; David Tuck; Seth M Steinberg; S Broder; Robert Yarchoan
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1112-21.
1998: R Little; Robert Wittes; Dan Longo; Wyndham H Wilson
Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):584-8.
1997: Julie T Feldstein; Elaine S Jaffe; PR Burd; H Kanegane; Douglas W Kingma; Wyndham H Wilson; Dan Longo; Giovanna Tosato
The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease.
Blood 1997;90(10):4099-105.
1997: Dan Longo; E Glatstein; PL Duffey; R C Young; D C Ihde; A W Bastian; Wyndham H Wilson; Robert Wittes; Elaine S Jaffe; Susan Molloy Hubbard; V T DeVita
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3338-46.
1997: MS Georgiadis; Barbara Schuler; J E Brown; LV Kieffer; Seth M Steinberg; Wyndham H Wilson; Chris H Takimoto; Michael J Kelley; Bruce E Johnson
Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):735-43.
1997: Wyndham H Wilson; Julie T Feldstein; T Fest; C Harris; Seth M Steinberg; Elaine S Jaffe; Mark Raffeld
Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.
Blood 1997;89(2):601-9.
1997: Elaine S Jaffe; Wyndham H Wilson
Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications.
Cancer surveys 1997;30():233-48.
1996: R Prussick; T D Horn; Wyndham H Wilson; M C Turner
A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha.
Journal of the American Academy of Dermatology 1996;35(5 Pt 1):705-9.
1996: Wyndham H Wilson; Douglas W Kingma; Mark Raffeld; R E Wittes; Elaine S Jaffe
Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.
Blood 1996;87(11):4531-7.
1996: Susan E Bates; Wyndham H Wilson; Antonio Tito Fojo; M Alvarez; Zhirong Zhan; JT Regis; Robert W Robey; C Hose; Anne Monks; Y K Kang; B Chabner
Clinical reversal of multidrug resistance.
Stem cells (Dayton, Ohio) 1996;14(1):56-63.
1995: Wyndham H Wilson; Susan E Bates; Antonio Tito Fojo; G Bryant; Zhirong Zhan; JT Regis; Robert Wittes; Elaine S Jaffe; Seth M Steinberg; J Herdt
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1995-2004.
1995: Wyndham H Wilson; CA Jamis-Dow; G Bryant; FRANK BALIS; Raymond W Klecker; Susan E Bates; B A Chabner; Seth M Steinberg; David R Kohler; Robert Wittes
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1985-94.
1995: MW Saville; J Lietzau; James M Pluda; IM Feuerstein; J Odom; Wyndham H Wilson; Rachel Humphrey; Ellen G Feigal; Seth M Steinberg; S Broder
Treatment of HIV-associated Kaposi's sarcoma with paclitaxel.
Lancet 1995;346(8966):26-8.
1995: Wyndham H Wilson; B A Chabner; G Bryant; Susan Bates; Antonio Tito Fojo; JT Regis; Elaine S Jaffe; Seth M Steinberg; Barry Goldspiel; Bruce D Cheson
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):381-6.
1994: Wyndham H Wilson; Stacey L Berg; G Bryant; Robert Wittes; Susan Bates; Antonio Tito Fojo; Seth M Steinberg; Barry Goldspiel; J Herdt; Joyce A O'Shaughnessy
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1621-9.
1993: Barry Goldspiel; David R Kohler; A G Koustenis; Wyndham H Wilson; A W Tolcher; Joyce A O'Shaughnessy; Robert Wittes; B A Chabner
Paclitaxel administration using portable infusion pumps.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2287-8.
1993: Wyndham H Wilson; G Bryant; Susan Bates; Antonio Tito Fojo; Robert Wittes; Seth M Steinberg; David R Kohler; Elaine S Jaffe; J Herdt; Bruce D Cheson
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(8):1573-82.
1992: Wyndham H Wilson; V Jain; G Bryant; Kenneth H Cowan; Charles Carter; M Cottler-Fox; Barry Goldspiel; Seth M Steinberg; Dan Longo; Robert Wittes
Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1712-22.